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Abstract 
Objective: This study aims to determine the relationship of risk factors with type of endometrial cancer.
Methods: This study used a cross sectional design in patients with endometrial cancer. Sampling uses total 
sampling technique, with a total sample of fifty six people. Data were obtained from the anatomical pathology 
section and medical records of Dr. RSUP M. Djamil Padang from 2016 until 2018. Analysis of data using Chi-
Square test and logistic regression
Result: In this study, type I endometrial cancer is 75% cases while type II is 25% cases. Age, parity, diabetes 
mellitus, hypertension, genetics history and exclusive breastfeeding have no association with the type of 
endometrial cancer. The age of menarche and BMI have a relationship with the type of endometrial cancer. The 
dominant factor associated with the type of endometrial cancer is BMI (p = 0.042; OR = 6.547; 95% CI = 1.067-
40.169), age (p = 0.037; OR = 4.854; 95% CI = 1.096-21.493), and age of menarche (p = 0.054; OR = 4.590; 95% 
CI = 0.974-21.635).
Conclusion: On this research, BMI, age and age of menarche are the most dominant factor associated with the 
type of endometrial cancer.
Faktor yang Berhubungan dengan Tipe Kanker Endometrium di RSUP 
Dr. M. Djamil Padang
Abstrak
Tujuan: Penelitian ini bertujuan untuk mengetahui hubungan faktor risiko dengan tipe kanker endometrium.
Metode: Penelitian ini menggunakan desain cross sectional pada penderita kanker endometrium. Pengambilan 
sampel menggunakan teknik total sampling, dengan jumlah sampel sebanyak 56 orang. Data diperoleh dari bagian 
patologi anatomi dan rekam medik RSUP Dr. M. Djamil Padang periode 2016 – 2018. Analisis data menggunakan 
uji Chi-Square dan regresi logistic.
Hasil: Pada penelitian ini ditemukan 75% kasus merupakan kanker endometrium tipe 1 dan 25% kanker 
endometrium tipe II. Usia, paritas, diabetes mellitus, hipertensi, riwayat genetik dan pemberian asi eksklusif tidak 
memiliki hubungan dengan tipe kanker endometrium. Usia menarche dan IMT memiliki hubungan dengan tipe 
kanker endometrium. Faktor yang dominan berhubungan dengan tipe kanker endometrium adalah IMT (p = 0,042; 
OR = 6,547; 95% CI = 1,067-40,169), usia (p = 0,037; OR = 4,854; 95% CI = 1,096-21,493), dan usia menarche 
(p = 0,054; OR = 4,590; 95% CI = 0,974-21,635).
Kesimpulan: Pada penelitian ini, IMT, usia dan usia menarche merupakan faktor yang paling dominan 
mempengaruhi tipe kanker endometrium
Kata kunci: Kanker Endometrium, Faktor Risiko.
Key words: Endometrial Cancer , Risk Factor  
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Introduction
Endometrial cancer is the sixth most often 
cancer in women throughout the world 
after breast, colon, lung, cervix and thyroid 
cancer. It is estimated that the incidence 
of this cancer reached 382,069 cases or 
about 4.4% of all cancer cases in women 
throughout the world in 2018.1 
The prevalence of endometrial cancer 
in developing countries is 4-5 times lower 
than in developed countries. At Dr. Cipto 
Mangunkusumo Hospital, Jakarta, 346 
(7.76%) cases of endometrial cancer from 
all cases of gynecological cancer in January 
2011−August 2016 were found.2 Based 
on data from study conducted by Dewi 
and Budiana in Sanglah General Hospital, 
Denpasar, from August 2012 to July 2014, the 
proportion of endometrial cancer compared 
to other gynecological cancers was 9.2% (56 
of 578 cases).3 
Endometrial cancer occurs during 
reproduction and menopause phase. The 
average age of patients with endometrial 
cancer is 63 years old, with the majority of 
patients aged 50−59 years old. Only about 
5% of women who suffer from endometrial 
cancer are less than 40 years old.4 
The causes of endometrial cancer are 
still not fully known, but most risk factors are 
associated with changes in hormonal patterns 
that occur throughout woman’s life. Estrogen 
has been proved to affect cells proliferation in 
the endometrium while progesterone has the 
opposite effect.5 There are several factors that 
increase the risk of endometrial cancer i.e. 
age, parity, early menarche, obesity, diabetes 
mellitus, hypertension, and genetic history.6 
Endometrial cancer consists of two 
types with different risk factors and 
prognosis. Type I endometrial cancer is 
associated with exposure to estrogen either 
endogenous or exogenous and begins with 
endometrial hyperplasia.7 Patients with type 
I endometrial cancer are younger and have 
a better prognosis than type II.8 In contrast, 
type II endometrial cancer is not estrogen-
dependent and develops independently from 
the pathway of endometrial hyperplasia. 
The incidence of type II endometrial cancer 
is less common than type I and the risk 
factors are less identified so that it is often 
detected at more advanced stage and tends 
to be more aggressive.9 Clinical features 
of type I endometrial cancer are conditions 
with increased estrogen exposure, similar as 
in nulliparous women, early menarche and 
obesity. Type II endometrial cancer often 
occurs in multiparous women, and is not 
obese.8 
Type I endometrial cancer is more common 
and has endometrioid histopathological 
appearance.10 Endometrial type II cancer has 
a less common histopathological appearance 
such as mucous, serous, clear cell, squamous, 
small cell, transitional cell, undifferentiated, 
and mixed cell carcinoma.11 
Methods
This study is an analytical observation 
study with a cross sectional approach. 
The study was conducted at the medical 
record installation and anatomy pathology 
laboratory of RSUP dr. M. Djamil Padang. 
The study was conducted from May 2018 to 
March 2019.
The population was patients with 
endometrial cancer at RSUP Dr. M. Djamil 
Padang in the period of 2016-2018. The 
sample was population that meets the 
inclusion criteria and does not have exclusion 
criteria. Inclusion criterium for the subject is 
all patients with endometrial cancer at RSUP 
Dr. M. Djamil Padang in 2016-2018 who 
had a histopathological examination. Subject 
exclusion criteria are patient medical record 
data that is incomplete or cannot be read 
clearly. Study samples were taken using total 
sampling techniques.
The data was collected from the medical 
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record installation of RSUP Dr. M. Djamil 
Padang in 2016-2018. Data taken are as 
follows: medical record number, patient’s 
age, parity, age of menarche, weight, height, 
body mass index, blood sugar level, blood 
pressure, history of cancer suffered by patients 
and families, history of breastfeeding and 
type of histopathological endometrial cancer
Data that has been collected by the 
researcher will be processed using a computer 
program. Data analysis was performed 
statistically using chi-square test and logistic 
regression.
Results
The study is conducted in the anatomy 
pathology laboratory and medical record 
installation at RSUP dr. M. Djamil Padang. 
The total sample of the study that fulfilled 
the inclusion criterium and did not have 
exclusion criteria were 56 patients. Based 
on the existing medical record data, the 
results are shown as follows. The frequency 
distribution of characteristics of endometrial 
cancer patients can be seen in table 1.
Tabel 1 Frequency distribution 
characteristics of endometrial 
cancer patients
No Characteristics F %
1 Age
≤50 th 33 58,9
>50 th 23 41,1
Total 56 100
2 Parity
Nulliparous (0) 14 25,0
Parous (≥1) 42 75,0
Total 56 100
3 Age of Menarche
Early Menarche (≤12 th) 29 51,8
Normal (>12) 27 48,2
Total 56 100
4 BMI
Obesity (≥30) 23 41,1
Non Obesity (<30) 33 58,9
Total 56 100
5 Diabetes Mellitus
a.    Yes 9 16,1
b.    No 47 83,9
Total 56 100
6 Hypertension
a.    Yes 20 35,7
b.    No 36 64,3
Total 56 100
7 History of Genetic Disease
a.    Yes 13 23,2
b.    No 43 76,8
Total 56 100
8 Exclusive breastfeeding
a.    Yes 25 59,5
b.    No 17 40,5
Total 42 100
9 Type of Cancer
a.    Type I Cancer 42 75,0
Type II Cancer 14 25,0
Total 56 100
Table 1 shows that most patients are ≤50 
years, have low parity, experience menarche 
at age ≤12 years, are not obese, do not suffer 
diabetes mellitus and hypertension and do 
not have a genetic history. In exclusive 
breastfeeding variables, nulliparous women 
were not included in the analysis. In this 
study, there were 14 patients who did not 
have children, so only 42 samples could be 
analyzed for this variable. This study shows 
that most endometrial cancer patients provide 
exclusive breastfeeding. Based on the type of 
endometrial cancer, it was found that most 
patients had type I endometrial cancer.
The correlation of risk factors with type 
of endometrial cancer can be seen in table 2.'
Based on the Chi-Square test results 
in table 2, it can be seen that there is a 
relationship between age of menarche and 
BMI with the type of endometrial cancer. 
Age, parity, diabetes mellitus, hypertension, 
genetic history and exclusive breastfeeding 
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were not statistically related to the type of 
endometrial cancer.
To find out the most dominant 
independent variables affecting the 
dependent variable logistic, regression test 
was performed. The dominant factors that 
influence the type of endometrial cancer can 
be seen in table 3. Table 3 shows that the age, 
the age of menarche and BMI variables are 
closely related to the type of endometrial 
cancer.
Tabel 2   The relationship of risk factors with type of endometrial cancer 
Variables
Endometrial Cancer
p ValueType I Type II
F % F %
Age
   ≤50 th 28 84,8 5 15,2 0,085
   >50 th 14 60,9 9 39,1
Parity
   Nulliparous (0) 12 85,7 2 14,3 0,478
   Parous (≥1) 30 71,4 12 28,6
Age of Menarche
   Early Menarche (≤12 th) 26 89,7 3 10,3 0,021
   Normal (>12 th) 16 59,3 11 40,7
BMI
   Obesity (≥30) 21 91,3 2 8,7 0,041
    Non Obesity (<30) 21 63,6 12 36,4
Diabetes Mellitus
    Yes 8 88,9 1 11,1 0,424
    No 34 72,3 13 27,7
Hypertension
    Yes 17 85,0 3 15,0 0,334
    No 25 69,4 11 30,6
Genetic History
    Yes 10 76,9 3 23,1 1,000
    No 32 74,4 11 25,6
Exclusive breastfeeding 
    Yes 19 76,0 6 24,0 0,498
    No 11 64,7 6 35,3
Variables B Wald p Value OR
95% CI
Lower Upper
Age 1,580 4,331 0,037 4,854 1,096 21,493
Age of Menarche 1,524 3,711 0,054 4,590 0.974 21,635
BMI 1,879 4,121 0,042 6,547 1,067 40,169
Tabel 3   The Dominant Factors that Influence the Type of Endometrial 
                  Cancer 
OR = odd ratio; CI = confidence interval
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Discussion
Characteristics of Age and Its Correlation 
with Type of Endometrial Cancer 
This study showed that most patients with 
endometrial cancer were ≤50 years old. This 
is in accordance with the study conducted 
by Effendi, Firdiawati and Rustam in RSUD 
Arifin Achmad Pekanbaru which found that 
most patients with endometrial cancer ranged 
in age from 41-50 years.6 In Indonesia, age 
of patients tends to be younger than those 
in western and European countries, possibly 
because the use of TSH is still very rare.5 
Endometrial cancer is divided into 
type I cancer (estrogen-dependent) and type 
II cancer (estrogen-independent). Type I 
endometrial cancer tends to affect younger 
women and is associated with a history of 
hyperestrogenism. Type II endometrial cancer 
usually occurs in older postmenopausal 
women where estrogen level decreases. This 
indicates that type II endometrial cancer may 
not be caused by estrogen excess.12
In this study, there was no significant 
correlation between age and type of 
endometrial cancer. This is in accordance 
with the study of Jaishuen, Kunakornporamat, 
Viriyapak, Benjapibal, Petsuksiri, et al. at 
Siriraj Hospital which showed no difference 
in the average age of type I and II endometrial 
cancer with p value = 0.86.13 
There was no significant correlation 
between age and type of endometrial cancer 
which is also proven by the study of Wan, 
Gao, Zeng, Yin, Zhao, et al. In the study, 
it was found that there were no differences 
in circulating estradiol, progesterone, 
testosterone, FSH and LH levels between 
patients with type I and II endometrial cancer 
in both premenopausal and postmenopausal 
women.14 In addition, other studies have 
shown that type I and II endometrial cancer 
have same risk factors for each of both and 
there was also a hypothesis that type II 
endometrial cancer may not be absolutely 
estrogen-independent.15 
In this study, 75% of cases were type 
I endometrial cancer and 25% type II 
endometrial cancer. With a few number of 
cases of type II endometrial cancer identified 
in this study causes this type to be more 
difficult to learn.13
 
Characteristics of Parity and Its 
Correlation with Type of Endometrial 
Cancer 
This study shows that most patients with 
endometrial cancer are parous women. This 
is in accordance with the study of Dewi and 
Budiana which showed that 80% of patients 
with endometrial cancer are parous women.3
Nulliparity increases the risk of 
developing endometrial cancer by up to four 
times, while multiparity reduces the risk of 
endometrial cancer by up to 70%. This is 
because parity causes changes in hormonal 
balance towards increasing progesterone 
and decreasing estrogen and the release of 
endometrial tissue during labor which can 
eliminate precancerous cells.9
Based on the study, it was found that 
there was no significant correlation between 
parity and endometrial cancer type (p value 
≥0.05). This is in accordance with the study 
of Chen, Tong, Guo, Lau and Zhao which 
analyzed the correlation of parity with the 
type of endometrial cancer. In the study, it was 
found that the majority suffered from type I 
endometrial cancer (84.8%) and there was no 
statistical difference in the proportion of type 
I and type II endometrial cancer according to 
parity (p>0.05).16
The results of this study are surprising 
because a shift in the balance of progesterone 
and estrogen during pregnancy was 
considered to have a protective effect on 
the development of endometrial cancer and 
type II endometrial cancer was considered 
independent of estrogen.16 However, a study 
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reported that two types of endometrial 
cancer have common risk factors and the 
possibility that type II endometrial cancer is 
not absolutely estrogen-independent.15
Characteristics of Age of Menarche and 
Its Correlation with Type of Endometrial 
Cancer
This study shows that most endometrial 
cancer patients experienced menstruation 
for the first time in ≤12 years old.  This is 
in accordance with the study of Wang, Risch, 
Lu, Irwin, Mayne, et al. those who found cases 
of endometrial cancer had a younger age of 
menarche than controls              (p=0.005).17
Menarche in early age is positively 
associated with some cancers in women such 
as breast, endometrial and ovarian cancer. 
This is because early menarche increases 
the number of menstrual cycles so that the 
total exposure time for estrogen will be 
increased. Early menarche increases the 
risk of endometrial cancer by up to 9 times 
compared with women who experienced 
menarche at older age.9 
Based on the study, it was found that 
there was a significant correlation between 
age of menarche and type of endometrial 
cancer (p value <0.05). The development 
of type I endometrium cancer is thought to 
be stimulated by estrogen and begun with 
endometrial hyperplasia. Risk factors for type 
I cancer include conditions with increased 
exposure to estrogen including menarche at 
early age.8 Unlike type I, type II risk factors 
are not widely known because there were 
few cases so it is difficult to study this type 
separately.18
Characteristics of BMI and Its Correlation 
with Type of Endometrial Cancer
This study shows that most endometrial 
cancer patients are not obese. Similar results 
were also found in the study of Pradjatmo and 
Pahlevi which showed that of 68 endometrial 
cancer patients, 61.8% had a normal BMI 
(18.5−24.9).19 The relationship of obesity to 
endometrial cancer is largely due to its effect 
on estrogen.17 Obesity increases estrogen 
levels in postmenopausal women and reduces 
progesterone levels in premenopausal 
women.15
Based on the study, it was found that 
there was a significant correlation between 
BMI and endometrial cancer types (p value 
<0.05). Study by Felix, Weissfeld, Stone, 
Bowser, Chivukula, et al. showed that 36% 
of cases of type II endometrial cancer were 
obese while those of type I were 55%. Felix, 
Weissfeld, Stone, Bowser, Chivukula, et al. 
also found an inverse correlation between 
obesity and type II endometrial cancer.20 
The correlation between obesity and 
endometrial cancer is stronger in cases of type 
I endometrial cancer (estrogen-dependent). 
This is in accordance with the study of Felix, 
Weissfeld, Stone, Bowser, Chivukula, et al. 
which showed that cases of obesity have 
an OR value of 2.22 for type I endometrial 
cancer compared to type II.20 Although these 
findings are consistent with the estrogen 
hypothesis, there were other findings reported 
that increased BMI is also a risk factor for 
type II endometrial cancer. This is proven 
by the study of Bjorge, Engeland, Tretli 
and Weiderpass who reported that women 
with more weight and obesity consecutively 
had a chance of 1.26 and 1.94 times for the 
development of type II cancer.21 Based on 
these findings, BMI may have an important 
role in the development of all cases of 
endometrial cancer, but the effect seems to be 
stronger against type I endometrial cancer.20
Characteristics of Diabetes Mellitus and 
Its Correlation with Type of Endometrial 
Cancer
This study shows that most endometrial 
cancer patients do not suffer from diabetes 
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mellitus. This result is in accordance with the 
study of Dewi and Budiana at RSUP Sanglah 
Denpasar which found 11.5% of endometrial 
cancer patients had diabetes mellitus and 
88.5% did not suffer from diabetes mellitus.3
Women with diabetes mellitus have 2 to 
3-fold risk of endometrial cancer.11 Friberg 
Mantzoros and Wolk found that the risk is 
increased by more than 6- fold when diabetes 
was associated with obesity and increased 
by 10-fold when women with diabetes and 
obesity did not exercise. This reflects the 
combination of diabetes with obesity and low 
physical activity associated with an increased 
risk of endometrial cancer. Interventions to 
reduce weight and increase physical activity 
may have important implications in in term of 
preventing endometrial cancer in the future.22 
Based on the study, it was found that 
there was no significant correlation between 
the history of diabetes mellitus and the type 
of endometrial cancer. This is in accordance 
with the study of Setiawan, Yang, Pike, 
McCann, Yu, et al. who found a correlation 
between history of diabetes mellitus with 
both types of endometrial cancer with OR 
value 1.53 and 1.27.15 
Type II endometrial cancer is generally 
described as estrogen-independent, so it can 
be anticipated that exposure to estrogen and 
anti-estrogen will not be associated with risk 
factors for type II cancer. However, in a study 
conducted by Setiawan, Yang, Pike, McCann, 
Yu, et al. identified a correlation between 
estrogenic and risk factors for type II cancer. 
This suggests that risk factors related to 
estrogen proliferation or related mechanisms 
involving estrogen are also important for 
type II cancer. For example, the mechanism 
associated with obesity, hyperinsulinemia 
which is also a feature of type 2 diabetes 
mellitus, was found to be associated with 
type II tumors.15 
Characteristics of Hypertension and Its 
Correlation with Type of Endometrial 
Cancer
This study shows that most endometrial 
cancer patients do not have a history of 
hypertension. This result is in accordance 
with the study of Dewi and Budiana at RSUP 
Sanglah Denpasar which found 11.5% of 
endometrial cancer patients had a history of 
hypertension and 88.5% had no history of 
hypertension.3
Based on the study, it was found that 
there was no significant correlation between 
hypertension and endometrial cancer type 
(p value ≥0.05). Malik, Chisti, Aziz and 
Sheikh also conducted study by comparing 
risk factors including hypertension between 
type I and II endometrial cancer and obtained 
p value of 0.21. In this study, hypertension 
cannot be considered as a risk factor 
independently, because it can only be a risk 
factor if in obese people.18 
Characteristics of Genetic History and 
Its Correlation with Type of Endometrial 
Cancer
This study shows that most patients with 
endometrial cancer have no genetic history. 
Based on the study, it was found that there 
was no significant correlation between 
genetic history and type of endometrial 
cancer (p value ≥0.05). This is in accordance 
with the study of Malik, Chisti, Aziz and 
Sheikh that found a history of cancer in 
family is proportional for both type I and II 
endometrial cancer (p value =0.20).18
In the study by Wang, Risch, Lu, Irwin, 
Mayne, et al. it was found that genetic risk 
was significantly correlated with endometrial 
cancer without any other factor adjustment. 
This relationship became insignificant after 
the BMI and other factors were adjusted in the 
analysis. This explains that the genetic role in 
disease risk is relatively weak compared to 
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environmental and lifestyle exposure.17 
Characteristics of Exclusive Breastfeeding 
and Its Correlation with Type of 
Endometrial Cancer
This study shows that most endometrial 
cancer patients provide exclusive breast 
milk. Exclusive breastfeeding generally 
suppresses ovulation and maternal estrogen 
level. Decreasing estrogen level reduces 
endometrial mitosis and hence can reduce the 
risks of endometrial cancer. However, clear 
evidence for this association is still lacking.23 
The correlation between breastfeeding 
and the risk of endometrial cancer is 
biologically plausible because breastfeeding 
can suppress gonadotropin releasing 
hormones, inhibit ovarian follicle growth 
and reduce estradiol level. At this level, 
the mitosis of endometrial cells is barely 
occured.23 
Based on the study, it was found that 
there was no significant correlation between 
exclusive breastfeeding and the type of 
endometrial cancer. In the study of Jordan, 
Na, Johnatty, Wise, Adami, et al. exclusive 
breastfeeding does not differ substantially 
based on the type of endometrial cancer. 
Differences are influenced by race/ethnicity, 
BMI in early adulthood and the time since 
the last pregnancy, but the difference is not 
statistically significant.23 
The correlation between breastfeeding 
and endometrial cancer seems to be influenced 
by BMI. The body mass index can change 
that assosiation because obesity lowers 
level of sex hormone-binding hormones, 
increasing estrogen and testosterone which 
are available biologically. Estrone production 
in adipose tissue in obese women can negate 
the relative hypo-estrogenic state caused by 
the breastfeeding effect.23 
Conclusion
In this study, it can be concluded that there is 
a correlation between age of menarche and 
BMI with the type of endometrial cancer. The 
most dominant factors affecting the type of 
endometrial cancer are BMI, age and age of 
menarche.
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